AIP
PDSB icon

Ameritas Investment Partners’s PDS Biotechnology PDSB Stock Holding History

Ameritas Investment Partners’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,309
Closed -$9.14K – 3204
2024
Q1 		$9.14K Hold
2,309
– – ﹤0.01% 2838
2023
Q4 		$11.5K Hold
2,309
– – ﹤0.01% 2805
2023
Q3 		$11.7K Hold
2,309
– – ﹤0.01% 2776
2023
Q2 		$11.6K Buy
+2,309
New +$15.1K ﹤0.01% 2851
2018
Q2 		– Sell
-87
Closed -$2K – 3040
2018
Q1 		$2K Hold
87
– – ﹤0.01% 2929
2017
Q4 		$16K Hold
87
– – ﹤0.01% 2551
2017
Q3 		$18K Hold
87
– – ﹤0.01% 2484
2017
Q2 		$18K Buy
87
+42
+93% +$8.28K ﹤0.01% 2525
2017
Q1 		$8K Buy
+45
New +$8.91K ﹤0.01% 2761

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's PDSB Position: Q2 2024 in Review

Ameritas Investment Partners sold out of PDS Biotechnology (PDSB) in Q2 2024, closing a stake of 2,309 shares — an estimated $9.14K sold.

Ameritas Investment Partners first reported a position in PDSB in Q1 2017 and held it in 9 quarters. The position peaked at $18K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q2 2024.

  • Ameritas Investment Partners reported no remaining PDS Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,309 PDS Biotechnology shares in Q2 2024, an estimated $9.14K.
  • Ameritas Investment Partners first reported a position in PDS Biotechnology in Q1 2017 and held it in 9 quarters.
  • Ameritas Investment Partners's PDS Biotechnology position peaked at $18K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.